UQCRFS1

UQCRFS1 encodes the Rieske iron-sulfur protein, a catalytic subunit of mitochondrial respiratory Complex III whose biogenesis, maturation, and conformational dynamics are tightly orchestrated (PMID:23168492, PMID:31883641). Prior to membrane insertion, the matrix chaperone LYRM7/MZM1L binds and stabilizes UQCRFS1, holding it competent for incorporation into the late Complex III dimeric assembly intermediate (PMID:23168492), while the AAA-ATPase Bcs1 transports the folded protein across the inner membrane through a conformationally coupled concerted mechanism in which UQCRFS1 engages only the apo-state matrix cavity of Bcs1 (PMID:41183768). After incorporation, TTC19 docks onto the assembled dimer and clears the N-terminal processing fragments generated during in situ UQCRFS1 maturation, a step required to avoid fragment accumulation and structural impairment of the complex (PMID:28673544). Within assembled Complex III, the conserved tether of the Rieske head domain gates electron transfer between the quinol oxidation (Qo) site and cytochrome c1, and mutations in this tether or at the cytochrome b–head-domain interface shift its equilibrium position, altering electron transfer and promoting reactive oxygen species production (PMID:26504246, PMID:27032290). Bi-allelic loss-of-function variants in UQCRFS1 reduce protein abundance, impair mitochondrial import, and disrupt Complex III assembly and cellular respiration, establishing UQCRFS1 as the causal gene for a mitochondrial Complex III deficiency (PMID:31883641).

1. 1995 Medium

   Establishing the genomic identity and locus of the human Rieske Fe-S protein gene provided the foundation for subsequent disease and assembly studies.

   Evidence FISH mapping and cosmid library sequencing of exon-intron structure

   PMID:7721092

   Open questions at the time

   • Does not address protein function or assembly
   • No expression or localization data
2. 2012 High

   It was unknown how UQCRFS1 is maintained in a soluble, insertion-competent state before joining Complex III; identifying LYRM7/MZM1L as a dedicated matrix chaperone defined the pre-insertion stabilization step.

   Evidence Co-IP, blue-native PAGE, siRNA knockdown and complementation in human cell lines

   PMID:23168492

   Open questions at the time

   • Does not resolve how UQCRFS1 is handed off to the import machinery
   • Structural basis of the chaperone-substrate interaction not defined
3. 2015 High

   Whether the Rieske head-domain tether is functionally critical for electron transfer gating was unresolved; intragenic suppressors in the conserved tether established a 'spring-loaded' model linking tether mechanics to mitochondrial phenotypes.

   Evidence C. elegans intragenic suppressor screen with OXPHOS readouts plus yeast Rip1 mutagenesis

   PMID:26504246

   Open questions at the time

   • Direct demonstration in human protein not shown
   • Quantitative link between tether motion and electron transfer rate not measured
4. 2016 Medium

   It was unclear how disease-associated head-domain mutations cause pathology; mapping mutations at the cytochrome b–ISP head-domain interface showed they shift the head-domain equilibrium away from the Qo site and enhance ROS via semireverse electron transfer.

   Evidence Site-directed mutagenesis in Rhodobacter capsulatus, EPR spectroscopy, electron transfer assays

   PMID:27032290

   Open questions at the time

   • Bacterial surrogate for human mutations
   • ROS measured in vitro, not in patient cells
5. 2017 High

   The fate of UQCRFS1 N-terminal processing peptides after incorporation was unknown; TTC19 was shown to bind the assembled dimer and remove these fragments, preventing their accumulation and structural impairment.

   Evidence Ttc19 knockout mouse, human LOF cell lines, mass spectrometry of fragments, Complex III activity assays

   PMID:28673544

   Open questions at the time

   • Mechanism by which fragments are degraded after release not defined
   • Protease responsible for initial in situ cleavage not identified here
6. 2019 High

   Whether UQCRFS1 variants cause human mitochondrial disease was untested; bi-allelic LOF variants with complementation rescue confirmed UQCRFS1 as causal for Complex III deficiency.

   Evidence Patient-derived fibroblasts, BN-PAGE, oxygen consumption, lentiviral rescue

   PMID:31883641

   Open questions at the time

   • Genotype-phenotype correlation across patients not established
   • Tissue-specific consequences not addressed
7. 2025 Medium

   The molecular mechanism of folded-protein transport across the inner membrane was unresolved; HS-AFM revealed Bcs1 binds folded UQCRFS1 exclusively in its apo conformation through a concerted, conformationally coupled cycle.

   Evidence Single-molecule HS-AFM with nucleotide titration

   PMID:41183768

   Open questions at the time

   • Single lab, single study
   • Energetics of full translocation across the membrane not quantified
8. 2025 Low

   The breadth of UQCRFS1's cellular roles beyond OXPHOS was explored; knockdown studies showed a requirement in TNBC proliferation and tumor growth but no role in ductus arteriosus oxygen sensing.

   Evidence siRNA knockdown with proliferation/migration/xenograft assays; calcium and ETC assays in DASMC (preprint)

   PMID:40524231 PMID:bio_10.1101_2025.07.08.663799

   Open questions at the time

   • TNBC role lacks mechanistic pathway placement beyond OXPHOS phenotype
   • Negative oxygen-sensing result limited to one cell type and unreplicated

• How UQCRFS1 stability and Fe-S cofactor loading can be pharmacologically modulated, and whether this is exploitable, remains open.
• SP-2509 destabilization shown only by indirect CETSA-MS in a preprint without Fe-S reconstitution
• No direct structural evidence for compound-cofactor interaction